Research Article

Circulating Clusterin and Osteopontin Levels in Asthma and Asthmatic Pregnancy

Table 1

Clinical data and inflammatory parameters of the four study groups (median [interquartile range]).

HNP ()HP ()ANP ()AP ()

Age (years)29.5 34 35 31.5

Gestational age at sampling (weeks)NA35 NA24.5

Gestational age at delivery (weeks)NA39 NA38

Fetal birth weight (grams)NA3240 NA3250

(% of predicted)NANA97 94

PEF (% of predicted)NANA98 84.50

(% of predicted)NANA118 105

FEF 25–75% (% of predicted)NANA77 83

ACT total scoreNANA24 22

Daily dose of ICS (beclomethasone equivalent, µg)NANA200 650

Eosinophil cells (%)1.595 NA2.420 2

IL-6 (pg/mL)NANA1.795 1.935

CRP (mg/mL)3.0 NA3 4.845

Osteopontin (ng/mL)2.075 3.037 2.086 2.693

Clusterin (µg/mL)108.8 98.80 109.2 111.7

HNP: healthy nonpregnant; HP: healthy pregnant; ANP: asthmatic nonpregnant; AP: asthmatic pregnant; : forced expiratory volume in 1 second; PEF: peak expiratory flow rate; : airway resistance; : forced expiratory flow at 25–75% of forced vital capacity; ACT: asthma control test; ICS: inhaled corticosteroid; CRP: C-reactive protein; IL-6: interleukin-6; NA: not applicable. versus HNP; versus HP.